Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC2A5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MYRIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506853 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TBX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPSB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP2K7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SOX14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRAPPC9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GTSF1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR38 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GOLGA8A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGKC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BVES-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSMEM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AGK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM134B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STPG3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on